TCTR20190314002尚未招募2 期
Immunogenic response of different antigenic values: investigation of intradermal purified Vero cell rabies vaccine in healthy volunteers)
BIOGENETECH CO.,LTD0 个研究点目标入组 200 人开始时间: 2019年3月14日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 50 Years(—)
- 性别
- All
入选标准
- •1. Healthy volunteers Male or female, age 18 years or over, but not more than 50 years old
- •2. Ability to read and sign the patient information sheet and inform consent form
排除标准
- •1. Refuse to sign the patient information sheet and inform consent form.
- •2. Being a volunteer in another clinical research or having participated in other investigational product research within 4 weeks before entering a clinical trial or being in the equivalent period of 5 times the half-life for another investigational product.
- •3. Administration of full course of vaccine or at least 3 shots of rabies vaccine before or after contacting the disease.
- •4. Have a history of allergy to vaccine components in this study.
- •5. Used to receive serum from horses (such as antiseptic serum, tetanus, serum, rabies, diphtheria, etc.)
- •6. Have serious illnesses that are dangerous or may cause a risk of participating in a clinical trial.
- •7. Acquiring Corticosteroids, chloroquine or immunosuppressants or having a history of immunodeficiency.
- •8. History of drug addiction or alcoholism.
- •9. Pregnant or breastfeeding females.
研究者
相似试验
已完成
4 期
Comparition of immunity and reaction of bOPV vaccine and tOPV vaccine in routine immunization schedule, with or without IPV vaccine administration at DTP3 vaccine contact: A controlled trialCTRI/2013/06/003722World health Organization900
已完成
不适用
Comparative evaluation of immunogenicity and reactogenicity of monovalent type 2 and 3 oral poliovirus vaccines (mOPV 2 and mOPV3) versus trivalent oral poliovirus vaccine (tOPV), and bivalent oral poliovirus vaccine (bOPV) versus monovalent types 1 and 3 oral poliovirus vaccines, respectively: a randomised double-blind trialISRCTN64725429Panacea Biotec Limited (India)900
已完成
不适用
Study of immune parameters that may differ between HC and patients with MS : an explorative studyMS1000381610007951Multiple SclerosisNL-OMON37483School for Mental Health and Neuroscience100
已完成
不适用
Administration of influenza vaccineInfluenza vaccination.need for immunization against influenzaIRCT201009044683N1Shiraz University of Medical Sciences & Health Services110
已完成
1 期
Evaluation of heterosubtypic immune responses in older peopleISRCTN70837239niversity Hospitals of Leicester NHS Trust (UK)520
